The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...

Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...

Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine ...

Miltenyi Biotec has been honoured with the Special Recognition Award for Pioneering Work in Cell & Gene Therapy at the ...

A pastor shares his journey of resilience and finding purpose after being diagnosed with multiple myeloma in his 40s. Read ...

New York, NY (December 8, 2025) – A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same leukemia-causing gene mutation can have dramatically ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

A combination of two therapies, azacitidine and venetoclax, or aza-ven, outperformed intensive chemotherapy for acute myeloid leukemia in patients healthy enough to receive aggressive treatment, ...

Compared with white patients, Black patients with acute myeloid leukemia (AML) were on average more than five years younger at diagnosis, more than 30% more likely to die of their disease, and more ...

Forbes Asia today spotlights ten individuals and families across Asia-Pacific making significant, personal contributions to various charitable causes.

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States ...